Michigan Medicine Division Of Rheumatology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michigan medicine division of rheumatology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michigan Medicine Division Of Rheumatology Today - Breaking & Trending Today

Biodegradable nanoparticle used in medical sutures could help combat scleroderma

Investigators have discovered that a biodegradable nanoparticle used in medical sutures could combat a rare, sometimes-fatal autoimmune disease. ....

United States , John Varga , Emily Henderson , Michigan Medicine Division Of Rheumatology , Drug Administration , Michigan Medicine Division ,

PLG Nanoparticles Inhibit Skin and Lung Fibrosis

A biodegradable nanoparticle used in medical sutures has been identified to tackle a rare, often deadly inflammatory disease, according to researchers. ....

United States , John Varga , Division Of Rheumatology , Michigan Medicine Division Of Rheumatology , Drug Administration , Inhibit Skin , Lung Fibrosis , Michigan Medicine Division , Study Senior Author ,

Potential biomarker found for lung disease in scleroderma patients


Potential biomarker found for lung disease in scleroderma patients
The finding will indicate how aggressively physicians should treat patients with the associated condition.
Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma.
The recent study, published in
“Despite interstitial lung disease being the leading cause of death among scleroderma patients, there are very few markers that predict progression of the disease,” said John Varga, M.D., a corresponding author of the paper, chief of the Michigan Medicine Division of Rheumatology and associate director of the U-M Scleroderma Program. “CTRP9 is an entirely novel biomarker that has never been implicated in scleroderma. It will help physicians predict the course of the disease and identify those patients who would not need to be on aggressive treatment for their lung disease.” ....

United States , John Varga , Um Scleroderma Program , Michigan Medicine Division Of Rheumatology , Arthritis Care Research , Arthritis Care , Michigan Medicine , Michigan Medicine Division , Um Scleroderma , ஒன்றுபட்டது மாநிலங்களில் , ஜான் வர்கா , கீல்வாதம் பராமரிப்பு ஆராய்ச்சி , கீல்வாதம் பராமரிப்பு , மிச்சிகன் மருந்து , மிச்சிகன் மருந்து பிரிவு ,